Exane Derivatives’s Aurora Cannabis ACB Stock Holding History

Exane Derivatives’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$333	Sell	25 -19	-43%	-$476	﹤0.01%	621
2022 Q1	$1.77K	Hold	44	–	–	﹤0.01%	761
2021 Q4	$2.4K	Hold	44	–	–	﹤0.01%	652
2021 Q3	$3.07K	Hold	44	–	–	﹤0.01%	769
2021 Q2	$3.71K	Sell	44 -5,800	-99%	-$502K	﹤0.01%	788
2021 Q1	$544K	Buy	5,844 +5,800	+13,182%	+$648K	0.16%	138
2020 Q4	$3.68K	Hold	44	–	–	﹤0.01%	578
2020 Q3	$2.06K	Hold	44	–	–	﹤0.01%	563
2020 Q2	$5.5K	Buy	44 +39	+780%	+$4.44K	﹤0.01%	444
2020 Q1	$509	Sell	5 -1,117	-100%	-$200K	﹤0.01%	595
2019 Q4	$276K	Buy	1,122 +896	+396%	+$334K	0.05%	217
2019 Q3	$119K	Sell	226 -32	-12%	-$23.7K	0.02%	304
2019 Q2	$242K	Buy	258 +220	+579%	+$221K	0.04%	243
2019 Q1	$41.6K	Buy	+38	New	+$34K	0.01%	346

Other funds holding ACB

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Exane Derivatives's ACB Position: Q2 2022 in Review

Exane Derivatives reduced its Aurora Cannabis (ACB) stake by 43% in Q2 2022, selling an estimated $476 and leaving 25 shares worth $333. The position accounts for ﹤0.01% of the portfolio, ranked #621.

Exane Derivatives first reported a position in ACB in Q1 2019 and has held it in 14 quarters since. The position peaked at $544K in Q1 2021. 257 funds tracked by Wall St. Rank hold ACB as of Q2 2022.

Exane Derivatives held 25 shares of Aurora Cannabis worth $333 as of Q2 2022.
Exane Derivatives sold 19 Aurora Cannabis shares in Q2 2022, an estimated $476.
Aurora Cannabis made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #621 holding.
Exane Derivatives first reported a position in Aurora Cannabis in Q1 2019 and has held it in 14 quarters since.
Exane Derivatives's Aurora Cannabis position peaked at $544K in Q1 2021.
257 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.